New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
At the end of the current inspection, a 'Form 483' was issued with 5 observations which are procedural in nature and no data integrity issues were reported
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
Subscribe To Our Newsletter & Stay Updated
